DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE (dutasteride; tamsulosin hydrochloride) by Teva is 2 drugs with different mechanisms of action to improve symptoms in patients with bph: dutasteride, a 5-alpha-reductase inhibitor, and tamsulosin, an antagonist of alpha 1a -adrenoreceptors. Approved for symptomatic benign prostatic hyperplasia (bph) in men with an enlarged prostate, symptomatic bph in men with an enlarged prostate, prostate cancer. First approved in 2015.
Drug data last refreshed Yesterday
2 drugs with different mechanisms of action to improve symptoms in patients with BPH: dutasteride, a 5-alpha-reductase inhibitor, and tamsulosin, an antagonist of alpha 1A -adrenoreceptors. Dutasteride Dutasteride inhibits the conversion of testosterone to DHT. DHT is the androgen primarily…
Worked on DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects
Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States
Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State